Effects of raloxifene on normal breast tissue from premenopausal women

By Silva Benedito   Lopes Ione   Gebrim Luiz  

Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. : 99-103

Springer Publishing Company

Access to resources Recommend Favorite

Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide

By Johansson Harriet   Bonanni Bernardo   Gandini Sara   Guerrieri-Gonzaga Aliana   Cazzaniga Massimiliano   Serrano Davide   Macis Debora   Puccio Antonella   Sandri Maria   Gulisano Marcella   Formelli Franca   DeCensi Andrea  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 569-578

Springer Publishing Company

Access to resources Recommend Favorite

Possible Deleterious Effect of Tamoxifen in Premenopausal Women with Locoregional Recurrence of Breast Cancer

By Borner M.M.   Bacchi M.   Castiglione M.  

European Journal of Cancer, Vol. 32, Iss. 12, 1996-11 ,pp. : 2173-2176

Elsevier

Access to resources Recommend Favorite

Abnormal Radiosensitivity of Lymphocytes from Breast Cancer Patients with Excessive Normal Tissue Damage after Radiotherapy: Chromosome Aberrations after Low Dose-rate Irradiation

By Jones L.A.   Scott D.   Cowan R.   Roberts S.A.  

International Journal of Radiation Biology, Vol. 67, Iss. 5, 1995-05 ,pp. : 519-528

Informa Healthcare

Access to resources Recommend Favorite

Tamoxifen in High-risk Premenopausal Women with Primary Breast Cancer Receiving Adjuvant Chemotherapy. Report from the Danish Breast Cancer Co-operative Group DBCG 82B Trial

By Andersson M.   Kamby C.   Jensen M.-B.   Mouridsen H.   Ejlertsen B.   Dombernowsky P.   Rose C.   Cold S.   Overgaard M.   Andersen J.   Kjaer M.  

European Journal of Cancer, Vol. 35, Iss. 12, 1999-11 ,pp. : 1659-1666

Elsevier

Access to resources Recommend Favorite